308
Participants
Start Date
March 16, 2016
Primary Completion Date
April 3, 2017
Study Completion Date
May 15, 2017
Lyophilized albiglutide DCC pen injector
A fixed-dose, fully disposable pen injector system with a prefilled dual chamber glass cartridge (DCC) containing lyophilized albiglutide (30mg or 50mg) delivering an injection volume of 0.5mL.
Lyophilized albiglutide DCC pen injector matching placebo
A fixed-dose, fully disposable pen injector system with a prefilled DCC containing matching placebo delivering an injection volume of 0.5mL
Albiglutide liquid auto-injector
A fixed-dose, single use, disposable auto-injector containing albiglutide liquid (30mg or 50mg) in a prefilled glass syringe. The auto-injector delivers the albiglutide liquid in an injection volume of 0.6 mL for the 30mg dose and 1.0 mL for the 50mg dose.
Albiglutide liquid auto-injector matching placebo
A fixed-dose, single use, disposable auto-injector containing matching placebo in a prefilled glass syringe. The auto-injector delivers the matching placebo in an injection volume of 0.6 mL for the 30mg dose and 1.0 mL for the 50mg dose.
GSK Investigational Site, New Hyde Park
GSK Investigational Site, Altoona
GSK Investigational Site, Greensboro
GSK Investigational Site, Shelby
GSK Investigational Site, Columbia
GSK Investigational Site, Anderson
GSK Investigational Site, Snellville
GSK Investigational Site, Conyers
GSK Investigational Site, Fleming Island
GSK Investigational Site, Orlando
GSK Investigational Site, Hallandale
GSK Investigational Site, Hialeah
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Bradenton
GSK Investigational Site, Brooksville
GSK Investigational Site, New Port Richey
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Lexington
GSK Investigational Site, Columbus
GSK Investigational Site, Perrysburg
GSK Investigational Site, Norwood
GSK Investigational Site, Evansville
GSK Investigational Site, Troy
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Elgin
GSK Investigational Site, Chicago
GSK Investigational Site, Chesterfield
GSK Investigational Site, St Louis
GSK Investigational Site, Topeka
GSK Investigational Site, New Orleans
GSK Investigational Site, Lake Charles
GSK Investigational Site, Dallas
GSK Investigational Site, Arlington
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Katy
GSK Investigational Site, Spring
GSK Investigational Site, Schertz
GSK Investigational Site, San Antonio
GSK Investigational Site, San Antonio
GSK Investigational Site, Pharr
GSK Investigational Site, Littleton
GSK Investigational Site, Meridian
GSK Investigational Site, Murray
GSK Investigational Site, Phoenix
GSK Investigational Site, Chandler
GSK Investigational Site, Glendale
GSK Investigational Site, Albuquerque
GSK Investigational Site, Las Vegas
GSK Investigational Site, Lomita
GSK Investigational Site, Canyon Country
GSK Investigational Site, Van Nuys
GSK Investigational Site, Chula Vista
GSK Investigational Site, Spring Valley
GSK Investigational Site, Oceanside
GSK Investigational Site, San Diego
GSK Investigational Site, Tustin
GSK Investigational Site, Anaheim
GSK Investigational Site, Fresno
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Sacramento
GSK Investigational Site, Federal Way
GSK Investigational Site, Tacoma
GSK Investigational Site, Spokane
GSK Investigational Site, Clearwater
GSK Investigational Site, Maumee
Lead Sponsor
GlaxoSmithKline
INDUSTRY